Banphaeo General Hospital Collaborates with depa & AstraZeneca Thailand in Launching “Don’t Wait. Get Checked.” Campaign, Embraces AI to Detect Lung Cancer in Early Stage

Bangkok – Banphaeo General Hospital (Public Organization), in collaboration with the Digital Economy Promotion Agency (depa) and AstraZeneca Thailand, launches the “Don’t Wait. Get Checked” campaign. It aims to leverage AI technology to develop and increase early-stage lung cancer screening in Thailand. Mr Anutin Charnvirakul, deputy prime minister and public health minister, presides over the launch ceremony at Eden, 1st floor, CentralWorld.

The “Don’t Wait. Get Checked” campaign is a pilot initiative implemented by Banphaeo General Hospital, one of the leading hospitals in Smart Hospital and healthcare technology. It brings an exciting new Artificial Intelligence (AI) technology to patients in Thailand, detecting ever-smaller lung tumours on chest X-ray scans. The technology enhances the accuracy of early lung cancer diagnosis that could lead to earlier treatment. It is also one approach to reducing lung cancer mortality rate.

Dr Pornthep Pongtawigorn, Director of Banphaeo General Hospital (Public Organization), says, “Lung cancer is usually detected when patients are already in the most advanced staged or Stage 4. Most lung cancer patients start seeing doctors when tumours have already metastasised and become incurable. Treatment outcomes thus are not as good as expected. There is a low chance of survival rate. Detecting lung cancer at its onset has crucial importance. Banphaeo General Hospital accords importance to utilising digital innovations and technologies for the purpose. To improve lung cancer screenings with the help of digital solutions, our hospital has collaborated with the government and the private sectors in launching the “Don’t Wait. Get Checked” Project. This pilot initiative deploys digital technologies in lung cancer screenings, paving the way for doctors to diagnose and treat patients with greater accuracy and efficiency”. 

The “Don’t Wait. Get Checked” campaign is a project under the memorandum of understanding on “Supporting and Promoting Healthcare Technology Development in Thailand” between depa and AstraZeneca Thailand, which supports the development of digital technology for public health services.  Asst. Prof. Dr Nuttapon Nimmanphatcharin, President – Digital Economy Promotion Agency (depa), says, “Nowadays, technology ฟืก digital innovations have played an important role in various fields including healthcare. As an active supporter of the development of digital industries and significant digital innovation in the country, we are pleased to see positive results of digital technology adoption in public health services in Thailand. The “Don’t Wait. Get Checked” is a key milestone in line with our mission to drive Digital Health to support of Thailand’s public health services”.

Mr James Teague, Country President AstraZeneca (Thailand), says, “Lung cancer is one of the leading causes of mortality in Thailand. The incidence rate of lung cancer has been increasing worldwide across and here in Thailand.  AstraZeneca Thailand recognises the increasingly important role technology can play in the diagnosis and management of patients.  Artificial Intelligence (AI) technology has demonstrated that it can support accurate and timely detection of abnormalities in the body that requires further physical examination.

The system we launch today with our partners enables fast detection to within 3 minutes, and in a convenient location. AstraZeneca is very pleased to cooperate with Ban Phaeo General Hospital, one of the leading hospitals in Smart Hospital and healthcare technology. AstraZeneca Thailand will continue to collaborate with public health authorities and public and private partners to advance healthcare systems and economies, helping to increase their resilience and sustainability for the benefit of societies”

The “Don’t Wait. Get Checked” campaign has received support from Central Group, a leader in retail and service business in Thailand and overseas. Central Group stands by people in Thailand by improving the public health system in a 360-degree approach under ‘Central Tham’ campaign. They provide venues and tools to facilitate convenient access and extensive early lung cancer screening.

Interested people may get free lung x-ray tests at the “Don’t Wait. Get Checked” event. The event runs from 4pm – 7pm on 20 April 2022, and from 11am – 7pm on 21-24 April 2022, 1st floor, Eden zone, CentralWorld, and at mobile screening units at Central’s branches such as Robinson Ladkrabang, Central Eastville, Central Ladprao, Central Pinklao, and Central Rama 2. For lung cancer screening schedules and more information, please check out Banphaeo General Hospital Public Organization (@BGHHOSP).

About Banphaeo General Hospital 

Banphaeo General Hospital (Public Organization) was once a 30-bed state hospital, which was developed from a health station. Through constant development, it has now been a 350-bed general hospital. It is also the first and only hospital to operate as a public organization in Thailand. After it was established under the Royal Decree on Banphaeo Hospital (Public Organization) Establishment B.E. 2543, it has mainly provided primary care with its branches covering not just Samut Sakhon’s Ban Phaeo district but also Bangkok. Its medical services include all specialized fields and aim at achieving high standards. The hospital, moreover, seeks to curb its dependence on state budget. Backed by capable medical team, it can lower patient referrals to Bangkok. Banphaeo General Hospital is able to treat complicated illnesses, promote good health, prevent diseases, and rehabilitate patients’ health. It accepts patients referred by other medical facilities in the Public Health Ministry’s Health Area 5.

About AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.